by Mariano Barbacid, The Conversation Pancreatic ductal adenocarcinoma (PDAC), the most common form of pancreatic cancer, is the fifth most common cause of death from cancer in the UK and the third in the United States. Deaths from PDAC outnumber those from breast cancer despite the significant difference in incidence rates. Late diagnosis and ineffective treatments are the most important reasons for these bleak...
Tag: <span>diagnosis</span>
Post
AI can predict breast cancer risk up to 5 years before diagnosis
By Kate Bass, B.Sc. Reviewed by Kate Anderton, B.Sc. (Editor) A team of researchers at the Massachusetts Institute of Technology (MIT) have developed a deep learning model that can predict breastcancer from mammogram images up to five years before a diagnosis can be made by doctors. Breast cancer is the most common cancer in women and is responsible for around 500,000 deaths each year worldwide. There are now many effective treatments for breast cancer, but...
Post
Experimental drug shows promise for genetic form of ALS
by American Academy of Neurology An early stage trial of an investigational therapy for amyotrophic lateral sclerosis (ALS) suggests that people could tolerate the experimental drug and, in exploratory results, the experimental drug was linked to possible slower progression in people with a genetic form of the disease caused by mutations in a gene called superoxide dismutase 1 (SOD1). The preliminary study released today will...
Post
Girls and boys on autism spectrum tell stories differently, could explain ‘missed diagnosis’ in girls
by Children’s Hospital of Philadelphia Boys are four times more likely than girls to be diagnosed with autism spectrum disorder (ASD), yet a growing body of research shows that the condition is more common in girls than previously thought, strongly suggesting that new methods are required to diagnose the disorder at younger ages. A new study from Children’s Hospital of Philadelphia (CHOP) examined differences...
Post
A1c test misses many cases of diabetes
THE ENDOCRINE SOCIETY NEW ORLEANS–Using the hemoglobin A1c blood test to diagnose diabetes tends to underestimate the prevalence of the disease, according to a new study to be presented Saturday, March 23 at ENDO 2019, the Endocrine Society’s annual meeting in New Orleans, La. “Based on our findings, A1c should not be solely used to determine the prevalence of diabetes,” said lead researcher Maria...
Post
Google and Verily Roll Out Automated Eye Screenings in India
Verily, the life sciences research arm of Alphabet, and Google, the original part of the now giant company, are launching in India a screening program to identify people with diabetic retinopathy (DR) and diabetic macular edema (DME). The program relies on an automated machine learning algorithm, developed over the past few years by Verily and that just receive the European CE mark, that doesn’t...
Post
A Simple Blood Test Is as Effective as a Biopsy in Detecting Lung Cancer Mutations
Biopsies are a necessary burden for people with cancer. Taking a small sample of tissue and sending it through genetic and molecular analysis can help doctors not just diagnose cancer, but also learn more about its inner workings to find the best treatments based on which mutations are feeding the disease. But tissue biopsies are...
Post
Family members could play key role in identifying dementia warning signs before diagnosis, new study finds
A new study has revealed that family caregivers and professional care assistants can retrospectively identify signs of dementia in those who go on to develop the condition, which could lead to earlier diagnosis of the illness. The research carried out by Birmingham City University academics Catharine Jenkins and Dr. Gerald Feldman could help people to...
Post
Hepatocellular carcinoma diagnosis, prognosis and treatment may improve by identifying a protein
Analysing the levels of a protein called TonEBP could provide valuable insight into the likelihood of recurrence of hepatocellular carcinoma, an aggressive cancer of the liver, following its surgical removal. Drugs that target TonEBP could also be investigated for liver cancer treatment. Tonicity-responsive enhancer-binding protein (TonEBP) helps protect cells from stress, but also elevates the...
Post
Prostate cancer: New, quicker test to assess metastasis risk
People with prostate cancer are at risk of metastatic tumors forming. A newly developed test can assess this risk more quickly than existing tests and is also cheaper to run. According to the National Cancer Institute, about 11.2 percent of men will receive a prostate cancer diagnosis at some point in time. In 2015 — the...